A Novel Nanomicellar Combination of Fenretinide and Lenalidomide Shows Marked Antitumor Activity in a Neuroblastoma Xenograft Model
Isabella Orienti,1 Ferro Nguyen,2 Peng Guan,2 Venkatadri Kolla,2 Natalia Calonghi,1 Giovanna Farruggia,1 Michael Chorny,2 Garrett M Brodeur2 1Department of Pharmacy and Biotechnology, University of Bologna, Bologna 40127, Italy; 2Divisions of Oncology, Children’s Hospital of Philadelphia,...
Saved in:
Main Authors: | Orienti I (Author), Nguyen F (Author), Guan P (Author), Kolla V (Author), Calonghi N (Author), Farruggia G (Author), Chorny M (Author), Brodeur GM (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antiproliferative and Morphological Effects of Fenretinide Lipid Nanosystems in Colon Adenocarcinoma Cells
by: Lorenzo Anconelli, et al.
Published: (2024) -
Nanospermidine in Combination with Nanofenretinide Induces Cell Death in Neuroblastoma Cell Lines
by: Pietro Lodeserto, et al.
Published: (2022) -
Validated LC-MS/MS Assay for the Quantitative Determination of Fenretinide in Plasma and Tumor and Its Application in a Pharmacokinetic Study in Mice of a Novel Oral Nanoformulation of Fenretinide
by: Cristina Matteo, et al.
Published: (2024) -
Ameliorating the antitumor activity of lenalidomide using PLGA nanoparticles for the treatment of multiple myeloma
by: Veera Venkata Satyanarayana Reddy Karri, et al.
Published: (2017) -
Naxitamab Activity in Neuroblastoma Cells Is Enhanced by Nanofenretinide and Nanospermidine
by: Lucrezia Galassi, et al.
Published: (2023)